BAO Zhijun

photo
Name:
BAO Zhijun
Position:
Vice president of Huadong Hospital
Title:
PhD, Chief Physician, Professor, Doctoral Supervisor
TEL:
021-62498577
Email:
zhijunbao@fudan.edu.cn
Research Interests:
  1. Evidence-based Decision-making Research on Elderly Frailty Care                  

  2. Evidence-based Nursing Research                  

  3. Chronic Disease Management                  

BIOGRAPHY

Professor Bao Zhijun is the Vice president of Huadong Hospital, Chief Physician, Professor, an interdisciplinary doctoral advisor in Internal Medicine (Gastroenterology) and Geriatrics at Fudan University. Currently, he is a disciplinary leader in the field of geriatric medicine in Shanghai and the chief of a national key research and development project. He has been selected as a leading talent in Shanghai's medical field and a leading talent in Shanghai health science popularization. He is the deputy director of the National Geriatric Disease Clinical Medical Research Center and the director of the Shanghai Geriatric Clinical Key Laboratory. In the past five years, he has received funding from key research and development programs of the Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China (NSFC), Shanghai Municipal Science and Technology Commission, Shanghai Municipal Health Commission, Shanghai Municipal Education Commission, et al. Professor Bao and his research team is working on the standards and comprehensive intervention of elderly frailty in China, the mechanism of cellular aging related to fatty liver, elderly health assessment system, comprehensive intervention research on elderly sarcopenia, and evidence-based decision-making research on elderly frailty care Evidence based nursing research, etc. In recent years, he has published over 100 papers in core journals at home and abroad as lead author or corresponding author, including 29 SCI papers and 8 national invention patents. Offering elective courses for graduate and undergraduate students in 'Clinical Practice of Geriatrics' and 'Progress in Basic Geriatrics', among which 'Clinical Practice of Geriatrics' is a key course of the Municipal Education Commission. Undertake the teaching of courses such as 'Internal Medicine C', 'Diagnosis', and 'Clinical Decision and Case Analysis of Geriatrics', and he has published popular science books such as 'Knowledge and Action Integration Health Centenary - Home-based Health Self Management Manual for Elderly People', 'Q&A of Helicobacter pylori Infection', and 'Detailed Discussion of Musculosis'. He has trained 50 postdoctoral, doctoral, and master's students. Has won the second prize of the Shanghai Municipal Teaching Achievement Award in 2017 and 2022, the second prize of the Fudan University Graduate Teaching Achievement Award in 2021, the second prize of the Shanghai Medical Science and Technology Award in 2021, the third prize of the Shanghai Traditional Chinese Medicine Science and Technology Award in 2019, the Shanghai Nursing Science and Technology Award in 2018, and the first prize of the Fudan University Teaching Achievement Award in 2017.

EDUCATION & TRAINING

  • Sep., 2003 – July, 2006: PhD

    study: Internal Medicine, Shanghai Jiao Tong University

  • Sep., 1995 - July, 1998:

    Master study: Public Health Management, Fudan University

  • Sep. 1988 – July, 1993:

    Bachelor Study: School of Medicine, Shanghai Jiao Tong University (former Shanghai Second Medical University)

TEACHING & RESEARCH

Teaching Areas:

Internal Medicine (Gastroenterology), Geriatrics

Research Grants:

  1. 2022.9-2024.8: Senile Weakness - An invisible killer that cannot be neglected. Health Science Popularization Leading Talent Ability Enhancement Project. Shanghai Municipal Health Commission. 200000 RMB, 2022.9-2024.8, PI.

  2. 2022.7-2023.6: Screening criteria for elderly frailty. Shanghai Municipal Health Local Standard Pre research Project. Shanghai Municipal Health Commission. #2021WB04, 50000 RMB, 2022.7-2023.6,PI.

  3. 2021.8-2022.8: Cognition and prevention of frailty in the elderly. Health Science Popularization Special Plan. Shanghai Municipal Health Commission. 100000 RMB, 2021.8-2022.8, PI.

  4. 2021.1-2024.12: The Role and Mechanism of Gal-3/CD36 Interaction in the Aging microenvironment hepatocyte Lipid Metabolism Driving Network. National Natural Science Foundation of China (NSFC). National Fund Commission. #82071581, 560000 RMB, 2021.1-2024.12, PI.

  5. 2019.7-2022.6: Early screening and prevention of frailty in the elderly. Leading Medical Talents in Shanghai.#2019LJ09, 450000 RMB, 2019.7-2022.6, PI.

  6. 2019.11-2022.10: Geriatric Department. Shanghai Municipal Health Commission (Shanghai 'Strong Subject' Clinical Key Specialty Construction Project). Shanghai Municipal Health Commission. #shslczdzk02801. 8913300 RMB, 2019.11-2022.10, PI.

  7. 2018.12-2023.12: Diagnostic criteria and comprehensive intervention study on frailty in the elderly population of China. Ministry of Science and Technology of the People's Republic of China. National Key Research and Development Projects. #2018YFC2002000. 19250000 RMB, 2018.12-2023.12, PI.

ACADEMIC SERVICE

  • Vice President of Huadong Hospital Affiliated to Fudan University

  • Vice Chairman of the China Geriatrics Research Institute Alliance

  • Vice Chairman of the Aging and Anti aging Committee of the Chinese Gerontology and Geriatrics Society

  • Standing Committee Member of the Chronic Disease Branch of the Chinese Gerontology and Geriatrics Society

  • Gerontology and Geriatrics Society, Vice President of the Shanghai Gerontology Society

  • Chairman of the Gerontology Healthcare Professional Committee of the Shanghai Gerontology Society

  • Executive Director of the Shanghai Medical Association

  • The director of the editorial department of Geriatrics and Health Care

  • editorial board member for 10 magazines including the Chinese Journal of Gastroenterology, Fudan Journal (Medical Edition), and Shanghai Medicine.

SELECTED PUBLICATIONS

  1. Fangyuan Dong#, Hui Li#, Limin Liu6#, Linli Yao#, Jiaofeng Wang, Danni Xiang, Jianxia Ma, Gansheng Zhang, Shan Zhang, Jun Li, Shu-Heng Jiang*, Xiaona Hu*, Jie Chen*, Zhijun Bao*. ACE2 negatively regulates the Warburg effect and suppresses hepatocellular carcinoma progression via reducing ROS-HIF1α activity. International Journal of Biological Sciences,2023; 19(8): 2613-2629.

  2. Bo Ye# , Yi Wang#, Hao Chen , Yingwei Chen , Huihui Yan, Hua Fu , Zhijun Bao*, Junling Gao* ,Development and Validation of the Chinese Frailty Screening Scale: A Study among Community-Dwelling Older Adults in Shanghai, International Journal of Environmental Research and Public Health. 2022 Sep 19;19(18):11811.

  3. Yuxin Huang# , Xudan Lou# , Cuiping Jiang , Xueying Ji, Xiaoming Tao* , Jiao Sun , Zhijun Bao* ,Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes, Frontiers in Endocrinology (Lausanne). 2022 Nov 17;13:1044030.

  4. Fangyuan Dong # , Rongkun Li # , Jiaofeng Wang # , Yan Zhang , Jianfeng Yao , Shu-Heng Jiang , Xiaona Hu , Mingxuan Feng , Zhijun Bao* .Hypoxia-dependent expression of MAP17 coordinates the Warburg effect to tumor growth in hepatocellular carcinoma. Journal of Experimental and Clinical Cancer Research. 2021 Apr 8;40(1):121.

  5. Fan Yang , Fan Zhang , Xueying Ji , Xin Jiang, Mengjuan Xue , Huiyuan Yu , Xiaona Hu, Zhijun Bao*  .Secretory galectin-3 induced by glucocorticoid stress triggers stemness exhaustion of hepatic progenitor cells. Journal of Biological Chemistry, 2020 Dec; 4;295(49):16852-16862.

  6. Yixuan Qiu , Jiaming Yu , Yi Li 4 5, Fan Yang , Huiyuan Yu , Mengjuan Xue , Fan Zhang, Xin Jiang, Xueying Ji , Zhijun Bao*. Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling. Annals of Medicine. 2021Jan;53(1):508-522.

  7. Fan Zhang # , Mengjuan Xue # , Xin Jiang , Huiyuan Yu , Yixuan Qiu , Jiaming Yu , Fan Yang, Zhijun Bao* . Identifying SLC27A5 as a potential prognostic marker of hepatocellular carcinoma by weighted gene co-expression network analysis and in vitro assays. Cancer Cell International. 2021Mar;17;21(1):174.

  8. Min Zhang , Zhaori Bi, Xinping Fu , Jiaofeng Wang , Qingwei Ruan , Chao Zhao , Jirong Duan , Xuan Zeng , Dian Zhou , Jie Chen, Zhijun Bao* . A parsimonious approach for screening moderate-to-profound hearing loss in a community-dwelling geriatric population. BMC Geriatrics. 2019 Aug; 7;19(1):214.

  9. Dong Fangyuan#,Yang Qin#, Wu Zheng#, Hu Xiaona, Shi Dongmei, Feng Mingxuan, Li Jun, Zhu Lili, Jiang Shuheng*, Bao Zhijun*. Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses. Biomedicine & Pharmacotherapy, 2019, 114: 108856.

  10. Fangyuan Dong#, Shuheng Jiang#, Jun Li, Yahui Wang, Lili Zhu, Yiqin Huang, Xin Jiang, Xiaona Hu*, Qi Zhou*, Zhigang Zhang*, Zhijun Bao*. The histone demethylase KDM4D promotes hepatic fibrosis by modulating Toll-like receptor 4 signaling pathway. EBioMedicine, 2019, 39:472-483.

Updated On:2023-11-08